The Effect of Adding Exercise Training to Optimal Therapy in PAH

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Pulmonary Arterial Hypertension
Interventions
OTHER

Exercise therapy

"3-week residential phase and 12-week outpatient phase.~Residential phase~* Exercise will be supervised by a physiotherapist and prescribed based on cardiopulmonary exercise testing.~* A monitored daily program of exercise involving bicycle ergometry, walking, breathing exercises, dumbbell exercises 5 days per week.~* 1.5 to 2 hours of exercise will be performed daily, with rest intervals.~* At weekends, lower intensity, unsupervised exercise mirroring the outpatient phase~* Ongoing exercise prescription will be based on tolerability, progress and HR~Outpatient phase~* A training manual will be compiled based on the subjects exercise performance during the residential program and tailored specifically to their needs~* Participants will be provided with a cycle ergometer, weights and a HR monitor~* Weekly telephone contact will be made by the study doctor or physiotherapist, with adjustments made to training prescription as necessary"

Trial Locations (1)

G81 4DY

Dr Martin Johnson, Glasgow

All Listed Sponsors
lead

National Health Service, United Kingdom

OTHER_GOV

NCT02961023 - The Effect of Adding Exercise Training to Optimal Therapy in PAH | Biotech Hunter | Biotech Hunter